Literature DB >> 29491039

The N54-αs Mutant Has Decreased Affinity for βγ and Suggests a Mechanism for Coupling Heterotrimeric G Protein Nucleotide Exchange with Subunit Dissociation.

John H Cleator1, Christopher A Wells2, Jane Dingus2, David T Kurtz2, John D Hildebrandt2.   

Abstract

Ser54 of Gsα binds guanine nucleotide and Mg2+ as part of a conserved sequence motif in GTP binding proteins. Mutating the homologous residue in small and heterotrimeric G proteins generates dominant-negative proteins, but by protein-specific mechanisms. For αi/o, this results from persistent binding of α to βγ, whereas for small GTP binding proteins and αs this results from persistent binding to guanine nucleotide exchange factor or receptor. This work examined the role of βγ interactions in mediating the properties of the Ser54-like mutants of Gα subunits. Unexpectedly, WT-αs or N54-αs coexpressed with α1B-adrenergic receptor in human embryonic kidney 293 cells decreased receptor stimulation of IP3 production by a cAMP-independent mechanism, but WT-αs was more effective than the mutant. One explanation for this result would be that αs, like Ser47 αi/o, blocks receptor activation by sequestering βγ; implying that N54-αS has reduced affinity for βγ since it was less effective at blocking IP3 production. This possibility was more directly supported by the observation that WT-αs was more effective than the mutant in inhibiting βγ activation of phospholipase Cβ2. Further, in vitro synthesized N54-αs bound biotinylated-βγ with lower apparent affinity than did WT-αs The Cys54 mutation also decreased βγ binding but less effectively than N54-αs Substitution of the conserved Ser in αo with Cys or Asn increased βγ binding, with the Cys mutant being more effective. This suggests that Ser54 of αs is involved in coupling changes in nucleotide binding with altered subunit interactions, and has important implications for how receptors activate G proteins.
Copyright © 2018 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29491039      PMCID: PMC5870480          DOI: 10.1124/jpet.117.245779

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  38 in total

1.  Dominant negative mutants of transducin-alpha that block activated receptor.

Authors:  Michael Natochin; Brandy Barren; Nikolai O Artemyev
Journal:  Biochemistry       Date:  2006-05-23       Impact factor: 3.162

Review 2.  Heterotrimeric GTP-binding proteins: an expanding family of signal transducers.

Authors:  A M Spiegel
Journal:  Med Res Rev       Date:  1992-01       Impact factor: 12.944

3.  The N54 mutant of Galphas has a conditional dominant negative phenotype which suppresses hormone-stimulated but not basal cAMP levels.

Authors:  J H Cleator; N D Mehta; D T Kurtz; J D Hildebrandt
Journal:  FEBS Lett       Date:  1999-01-25       Impact factor: 4.124

4.  A dominant-negative Galpha mutant that traps a stable rhodopsin-Galpha-GTP-betagamma complex.

Authors:  Sekar Ramachandran; Richard A Cerione
Journal:  J Biol Chem       Date:  2011-02-01       Impact factor: 5.157

5.  Synthesis and use of biotinylated beta gamma complexes prepared from bovine brain G proteins.

Authors:  J Dingus; M D Wilcox; R Kohnken; J D Hildebrandt
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

6.  Functional analysis of a dominant negative mutant of G alpha i2.

Authors:  V Z Slepak; A Katz; M I Simon
Journal:  J Biol Chem       Date:  1995-02-24       Impact factor: 5.157

7.  G Protein betagamma dimer formation: Gbeta and Ggamma differentially determine efficiency of in vitro dimer formation.

Authors:  Jane Dingus; Christopher A Wells; Lia Campbell; John H Cleator; Kathryn Robinson; John D Hildebrandt
Journal:  Biochemistry       Date:  2005-09-06       Impact factor: 3.162

8.  Type II adenylylcyclase integrates coincident signals from Gs, Gi, and Gq.

Authors:  K D Lustig; B R Conklin; P Herzmark; R Taussig; H R Bourne
Journal:  J Biol Chem       Date:  1993-07-05       Impact factor: 5.157

9.  Characterization of transducin from bovine retinal rod outer segments. I. Separation and reconstitution of the subunits.

Authors:  B K Fung
Journal:  J Biol Chem       Date:  1983-09-10       Impact factor: 5.157

10.  A human homeotic transformation resulting from mutations in PLCB4 and GNAI3 causes auriculocondylar syndrome.

Authors:  Mark J Rieder; Glenn E Green; Sarah S Park; Brendan D Stamper; Christopher T Gordon; Jason M Johnson; Christopher M Cunniff; Joshua D Smith; Sarah B Emery; Stanislas Lyonnet; Jeanne Amiel; Muriel Holder; Andrew A Heggie; Michael J Bamshad; Deborah A Nickerson; Timothy C Cox; Anne V Hing; Jeremy A Horst; Michael L Cunningham
Journal:  Am J Hum Genet       Date:  2012-05-04       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.